A5074519357- Advanced Radiotherapy Techniques
- Breast Cancer Treatment Studies
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Treatments and Mutations
- Head and Neck Cancer Studies
- Cancer Diagnosis and Treatment
- Breast Lesions and Carcinomas
- Breast Implant and Reconstruction
- Radiomics and Machine Learning in Medical Imaging
- Neuroendocrine Tumor Research Advances
- Cancer, Hypoxia, and Metabolism
- Nonmelanoma Skin Cancer Studies
- Neuroblastoma Research and Treatments
- Radiation Dose and Imaging
- BRCA gene mutations in cancer
- Occupational and environmental lung diseases
- Pleural and Pulmonary Diseases
- Advances in Oncology and Radiotherapy
- Voice and Speech Disorders
- Colorectal and Anal Carcinomas
- Radiative Heat Transfer Studies
- Estrogen and related hormone effects
- Chemotherapy-related skin toxicity
- Effects of Radiation Exposure
- Management of metastatic bone disease
NYU Langone’s Laura and Isaac Perlmutter Cancer Center
2018-2024
NYU Langone Health
2018-2024
Columbia University Irving Medical Center
2013-2024
New York University
2017-2023
University of Balochistan
2021
Memorial Sloan Kettering Cancer Center
2014-2018
Background: Stereotactic body radiotherapy (SBRT) has been adopted as the standard of care for inoperable early-stage non-small cell lung cancer (NSCLC), with local control rates consistently >90%. However, data directly comparing outcomes SBRT those conventionally fractionated (CONV) is lacking.Material and methods: Between 1990 2013, 497 patients (525 lesions) NSCLC (T1-T2N0M0) were treated CONV (n = 127) or 398). In this retrospective analysis, five endpoints compared, without adjusting...
Patients with an in-breast tumor recurrence (IBTR) after breast-conserving therapy have a high risk of distant metastasis and disease-related mortality. Classifying clinical parameters that increase for IBTR remains challenge.To describe primary recurrent characteristics in patients who experience understand the relationship between these disease outcomes.Patients stage 0-II breast cancer treated lumpectomy adjuvant radiation were identified from institutional databases 2003-2017 at our...
The treatment of malignant pleural mesothelioma (MPM) remains challenging. Optimal management for resectable patients involves an aggressive approach, frequently using trimodality therapy. Historically, poor tumor control and profound pulmonary toxicity prevented conventional radiation therapy from being widely used. advent intensity-modulated was a major development in the delivery MPM adjuvant setting, improving target coverage dose homogeneity while maintaining acceptable profiles....